Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.

Gray MJ, Dallas NA, Van Buren G, Xia L, Yang AD, Somcio RJ, Gaur P, Mangala LS, Vivas-Mejia PE, Fan F, Sanguino AM, Gallick GE, Lopez-Berestein G, Sood AK, Ellis LM. Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver. Oncogene. 2008 Dec 04; 27(57):7192-200.

View in: PubMed

authors with profiles

Pablo Vivas

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support